VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2016

Nov 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2016-11-15

Reporting Person: Sachdev Amit (EVP, Policy, Access & Value)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-15	Common Stock	S	116	$93.36	Disposed	86096	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	882	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.